Carregant...
Is It Safe to Stop Anti–PD-1 Immunotherapy in Patients With Metastatic Melanoma Who Achieve a Complete Response?
Guardat en:
| Publicat a: | J Clin Oncol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Clinical Oncology
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7238487/ https://ncbi.nlm.nih.gov/pubmed/32097093 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.00136 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|